Addiction Research Centres and the Nurturing of Creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
ABSTRACT The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a com...
Uloženo v:
| Vydáno v: | Addiction (Abingdon, England) Ročník 107; číslo 2; s. 254 - 258 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Oxford, UK
Blackwell Publishing Ltd
01.02.2012
|
| Témata: | |
| ISSN: | 0965-2140, 1360-0443, 1360-0443 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | ABSTRACT
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug‐related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. |
|---|---|
| AbstractList | The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. ABSTRACT The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug‐related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centers, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research center in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field.[PUBLICATION ABSTRACT] The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field.The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. Reprinted by permission of Blackwell Publishing The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual overview of European drug problems and a common information framework to support the drugs debate. In order to achieve its mission, the EMCDDA coordinates and relies on a network of 30 national monitoring centres, the Reitox National Focal Points. The Centre publishes on a wide range of drug-related topics, across epidemiology, interventions, laws and policies. Every November, the EMCDDA publishes its Annual Report, providing a yearly update on the European drug situation, translated into 23 EU languages. In line with its founding regulation, the EMCDDA has a role acting as an interface between the worlds of science and policy. While not a research centre in the formal sense, the results the Centre generates serve as catalysts for new research questions and help to identify priorities. Current challenges facing the agency include continuing to increase scientific standards while maintaining a strong institutional role, as well as supporting European efforts to identify, share and codify best practice in the drugs field. Adapted from the source document. |
| Author | Griffiths, Paul Götz, Wolfgang Lopez, Dominique Zobel, Frank Mounteney, Jane |
| Author_xml | – sequence: 1 givenname: Paul surname: Griffiths fullname: Griffiths, Paul email: paul.griffiths@emcdda.europa.eu organization: European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal – sequence: 2 givenname: Jane surname: Mounteney fullname: Mounteney, Jane organization: European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal – sequence: 3 givenname: Dominique surname: Lopez fullname: Lopez, Dominique organization: European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal – sequence: 4 givenname: Frank surname: Zobel fullname: Zobel, Frank organization: European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal – sequence: 5 givenname: Wolfgang surname: Götz fullname: Götz, Wolfgang organization: European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21539630$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1uEzEUhS1URNPAKyCLDWUxwX_zYySQQpIWRFOkKoil5Xo8icNkHGwPNK_Hk-HJtAW6oPXGlu53zr26PkfgoLGNBgBiNMLxvF6PMM1QghijI4IwHiFKMz66egQGt4UDMEA8SxOCGToER96vEUJ5wdkTcEhwSnlG0QD8GpelUcHYBl5or6VTKzjRTXDaQ9mUMKw0PG9daJ1pltBWcOK0DOaHCbsRnNvGBLuvdNysdXarZQNL1y6hN6GVnfGbfdE2S9uBaiXrWjdLDSvr_pX9ZdePsEem0ayfpXvBP_Mez-aT6XT86il4XMna62fX9xB8OZktJh-Ss8-nHyfjs0SlBeZJhYgitEwvS5qrPEszVPGKlYxQxrJK6YwQLFlexsVUpZIFYbSSOucUU06qVNEheNn7bp393mofxMZ4petaNtq2XnBCGE8LlN5P4izjWc478vi_JCZpXqSsiP95L4ooKqJtnHcIXtxB17Z1TVxO15oyRAoSoefXUHu50aXYOrORbidushGBdz2gnPXe6UooE_Y_Gpw0dWwoujCKtegyJ7rMiS6MYh9GcRUNijsGNz0eIH3bS3-aWu8erBPj6bR7RX3S640P-upWL903keU0T8XX81OxeL9YXMzZJ3FCfwPi1wUx |
| CODEN | ADICE5 |
| CitedBy_id | crossref_primary_10_1111_add_12570 crossref_primary_10_1111_add_12151 crossref_primary_10_36740_EmeMS202104105 crossref_primary_10_1016_j_drugalcdep_2025_112669 crossref_primary_10_1080_10826084_2016_1246571 crossref_primary_10_1111_bcp_14415 crossref_primary_10_1016_j_scitotenv_2013_10_034 crossref_primary_10_1159_000356812 crossref_primary_10_1111_add_13056 crossref_primary_10_1080_14659891_2022_2051621 crossref_primary_10_1016_j_drugalcdep_2018_01_036 crossref_primary_10_3389_fpsyt_2021_640120 crossref_primary_10_1186_s12954_017_0141_6 crossref_primary_10_1002_dta_333 crossref_primary_10_5812_ijhrba_67604 crossref_primary_10_1002_jcop_23053 crossref_primary_10_1016_j_forsciint_2023_111911 |
| Cites_doi | 10.1163/9789004642669_008 10.1111/j.1360-0443.2009.02874.x 10.1093/eurpub/cki168 |
| ContentType | Journal Article |
| Copyright | 2011 EMCDDA 2011 EMCDDA. |
| Copyright_xml | – notice: 2011 EMCDDA – notice: 2011 EMCDDA. |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7TK 8BJ FQK JBE K9. NAPCQ 7U3 BHHNA 7T2 C1K 7X8 |
| DOI | 10.1111/j.1360-0443.2011.03369.x |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Neurosciences Abstracts International Bibliography of the Social Sciences (IBSS) International Bibliography of the Social Sciences International Bibliography of the Social Sciences ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Social Services Abstracts Sociological Abstracts Health and Safety Science Abstracts (Full archive) Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium International Bibliography of the Social Sciences (IBSS) Neurosciences Abstracts Animal Behavior Abstracts Social Services Abstracts Sociological Abstracts Health & Safety Science Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | Health & Safety Science Abstracts MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic International Bibliography of the Social Sciences (IBSS) Social Services Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Social Welfare & Social Work |
| EISSN | 1360-0443 |
| EndPage | 258 |
| ExternalDocumentID | 2562299221 21539630 10_1111_j_1360_0443_2011_03369_x ADD3369 ark_67375_WNG_TBTTRM4K_F |
| Genre | article Journal Article Feature |
| GeographicLocations | Europe European Union |
| GeographicLocations_xml | – name: Europe – name: European Union |
| GroupedDBID | --- ..I .3N .GA .GJ .Y3 0-V 04C 05W 0R~ 10A 1OB 1OC 23M 2QV 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 6PF 702 7PT 7RV 7X7 8-0 8-1 8-3 8-4 8-5 88E 8C1 8FI 8FJ 8G5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABOCM ABPVW ABQWH ABUWG ABXGK ACAHQ ACBWZ ACCZN ACFBH ACGFO ACGFS ACGOF ACHQT ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMHG ADNMO ADOJX ADOZA ADXAS ADZJE ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFKRA AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIAGR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALSLI ALUQN ALVPJ AMBMR AMYDB AN0 ARALO ASPBG ATUGU AVWKF AZBYB AZFZN AZQEC AZVAB BAFTC BCR BCU BDRZF BEC BENPR BFHJK BGRYB BHBCM BKEYQ BLC BMSDO BMXJE BNQBC BPHCQ BROTX BRXPI BSCLL BVXVI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO DWQXO DXH EAD EAP EAS EBB EBC EBD EBS EBX ECF ECT EIHBH EJD EMB EMK EMOBN EPS ESI ESTFP ESX EX3 F00 F01 F04 F5P FD6 FEDTE FUBAC FYUFA FZ0 G-S GNUQQ GODZA GUQSH H.X HF~ HGLYW HMCUK HVGLF HZI HZ~ H~9 IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M0O M1P M2M M2O MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NAPCQ NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PRQQA PSQYO PSYQQ PUEGO Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SJFOW SUPJJ SV3 TEORI TUS UB1 UKHRP UPT V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WVDHM WXI WXSBR XG1 XIF XOL YFH YUY ZGI ZZTAW ~IA ~WT AAYXX ABUFD AFFHD CITATION O8X AAHHS ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE ALIPV CGR CUY CVF ECM EIF NPM 7QG 7TK 8BJ FQK JBE K9. 7U3 BHHNA 7T2 C1K 7X8 |
| ID | FETCH-LOGICAL-c5819-f02c23d5bd37c76560f9f4d423446fce6221a47d396fdca8243fae7931392f5c3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 16 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000299156100009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0965-2140 1360-0443 |
| IngestDate | Wed Oct 01 14:29:56 EDT 2025 Mon Sep 29 03:40:35 EDT 2025 Mon Oct 06 18:01:32 EDT 2025 Sun Sep 28 00:30:01 EDT 2025 Mon Nov 10 21:23:04 EST 2025 Thu Apr 03 06:56:47 EDT 2025 Sat Nov 29 05:58:29 EST 2025 Tue Nov 18 22:28:01 EST 2025 Sun Sep 21 06:24:58 EDT 2025 Sun Sep 21 06:15:28 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | 2011 EMCDDA. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5819-f02c23d5bd37c76560f9f4d423446fce6221a47d396fdca8243fae7931392f5c3 |
| Notes | istex:9C1999C9BE838445A7DC68C49561CAA70418B02D ark:/67375/WNG-TBTTRM4K-F ArticleID:ADD3369 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1360-0443.2011.03369.x |
| PMID | 21539630 |
| PQID | 916340282 |
| PQPubID | 37458 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_922495805 proquest_miscellaneous_916696795 proquest_miscellaneous_1257854844 proquest_miscellaneous_1030869631 proquest_journals_916340282 pubmed_primary_21539630 crossref_citationtrail_10_1111_j_1360_0443_2011_03369_x crossref_primary_10_1111_j_1360_0443_2011_03369_x wiley_primary_10_1111_j_1360_0443_2011_03369_x_ADD3369 istex_primary_ark_67375_WNG_TBTTRM4K_F |
| PublicationCentury | 2000 |
| PublicationDate | February 2012 |
| PublicationDateYYYYMMDD | 2012-02-01 |
| PublicationDate_xml | – month: 02 year: 2012 text: February 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England – name: Abingdon |
| PublicationTitle | Addiction (Abingdon, England) |
| PublicationTitleAlternate | Addiction |
| PublicationYear | 2012 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Hartnoll R. Drug epidemiology in the European institutions: historical background and key indicators. Bull Narc 2003; LV: 53-71. Hartnoll R., Avico U., Ingoid F. R., Lange K., Lenke L., O'Hare A. et al. A multi-city study of drug misuse in Europe. Bull Narc 1989; XLI: 3-27. Rhodes T., Hedrich D., editors. Harm Reduction: Evidence, Impacts and Challenges. EMCDDA Monograph.Luxembourg: EMCDDA; 2010. European Monitoring Centre for Drugs and Drug Addiction. Assessing Illicit Drugs in Wastewater. Potential and Limitations of A New Monitoring Approach. EMCDDA Insights. Luxembourg: EMCDDA; 2008. Griffiths P., Sedefov R., Gallegos A., Lopez D. How globalization and market innovation challenge how we think about and respond to drug use: 'spice' a case study. Addiction 2010; 105: 951-3. Bargagli A., Hickman M., Davoli M., Perucci C. A., Schifano P., Buster M. et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2005; 16: 198-202. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2010: The State of the Drug Problem in Europe. Luxembourg: EMCDDA; 2010. 2009 2008 1995 2006 2003; LV 2005; 16 2010 2010; 105 1989; XLI Rhodes T. (e_1_2_11_12_2) 2010 Estievenart G. (e_1_2_11_2_2) 1995 e_1_2_11_13_2 Bergeron H. (e_1_2_11_14_2) 2006 Hartnoll R. (e_1_2_11_3_2) 1989 e_1_2_11_8_2 e_1_2_11_7_2 e_1_2_11_10_2 e_1_2_11_6_2 e_1_2_11_5_2 Hartnoll R. (e_1_2_11_4_2) 2003 e_1_2_11_15_2 European Monitoring Centre for Drugs and Drug Addiction (e_1_2_11_11_2) 2008 European Monitoring Centre for Drugs and Drug Addiction (e_1_2_11_9_2) 2010 |
| References_xml | – reference: Bargagli A., Hickman M., Davoli M., Perucci C. A., Schifano P., Buster M. et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2005; 16: 198-202. – reference: Hartnoll R., Avico U., Ingoid F. R., Lange K., Lenke L., O'Hare A. et al. A multi-city study of drug misuse in Europe. Bull Narc 1989; XLI: 3-27. – reference: Rhodes T., Hedrich D., editors. Harm Reduction: Evidence, Impacts and Challenges. EMCDDA Monograph.Luxembourg: EMCDDA; 2010. – reference: Griffiths P., Sedefov R., Gallegos A., Lopez D. How globalization and market innovation challenge how we think about and respond to drug use: 'spice' a case study. Addiction 2010; 105: 951-3. – reference: European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2010: The State of the Drug Problem in Europe. Luxembourg: EMCDDA; 2010. – reference: European Monitoring Centre for Drugs and Drug Addiction. Assessing Illicit Drugs in Wastewater. Potential and Limitations of A New Monitoring Approach. EMCDDA Insights. Luxembourg: EMCDDA; 2008. – reference: Hartnoll R. Drug epidemiology in the European institutions: historical background and key indicators. Bull Narc 2003; LV: 53-71. – year: 2009 – volume: 16 start-page: 198 year: 2005 end-page: 202 article-title: Drug‐related mortality and its impact on adult mortality in eight European countries publication-title: Eur J Public Health – volume: XLI start-page: 3 year: 1989 end-page: 27 article-title: A multi‐city study of drug misuse in Europe publication-title: Bull Narc – volume: LV start-page: 53 year: 2003 end-page: 71 article-title: Drug epidemiology in the European institutions: historical background and key indicators publication-title: Bull Narc – volume: 105 start-page: 951 year: 2010 end-page: 3 article-title: How globalization and market innovation challenge how we think about and respond to drug use: ‘spice’ a case study publication-title: Addiction – start-page: 50 year: 1995 end-page: 97 – year: 2008 – start-page: 113 year: 2006 end-page: 24 – year: 2010 – start-page: 53 year: 2003 ident: e_1_2_11_4_2 article-title: Drug epidemiology in the European institutions: historical background and key indicators publication-title: Bull Narc – volume-title: Annual Report 2010: The State of the Drug Problem in Europe year: 2010 ident: e_1_2_11_9_2 – ident: e_1_2_11_6_2 – volume-title: Assessing Illicit Drugs in Wastewater. Potential and Limitations of A New Monitoring Approach year: 2008 ident: e_1_2_11_11_2 – start-page: 50 volume-title: Policies and Strategies to Combat Drugs in Europe year: 1995 ident: e_1_2_11_2_2 doi: 10.1163/9789004642669_008 – volume-title: Harm Reduction: Evidence, Impacts and Challenges year: 2010 ident: e_1_2_11_12_2 – ident: e_1_2_11_13_2 doi: 10.1111/j.1360-0443.2009.02874.x – ident: e_1_2_11_10_2 – start-page: 3 year: 1989 ident: e_1_2_11_3_2 article-title: A multi‐city study of drug misuse in Europe publication-title: Bull Narc – ident: e_1_2_11_7_2 – start-page: 113 volume-title: Drugs Policy and Politics year: 2006 ident: e_1_2_11_14_2 – ident: e_1_2_11_15_2 doi: 10.1093/eurpub/cki168 – ident: e_1_2_11_5_2 – ident: e_1_2_11_8_2 |
| SSID | ssj0007894 |
| Score | 2.1184566 |
| Snippet | ABSTRACT
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The... The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug‐related information in the European Union. The... The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 254 |
| SubjectTerms | Academies and Institutes - organization & administration Academies and Institutes - trends Addiction Annual reports Best practice Best practices Catalysts Creativity Criminal Justice Policy Drug Abuse Drug Addiction Drug Information Services - organization & administration Drug policy Drug use Drugs Epidemiology Europe European Union Forecasting Founding Health Policy Humans illicit drugs Information Storage and Retrieval Intervention Languages monitoring Networks Organizational Objectives policy Priorities Regulation Research centers Street Drugs - legislation & jurisprudence Substance-Related Disorders |
| Title | Addiction Research Centres and the Nurturing of Creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) |
| URI | https://api.istex.fr/ark:/67375/WNG-TBTTRM4K-F/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1360-0443.2011.03369.x https://www.ncbi.nlm.nih.gov/pubmed/21539630 https://www.proquest.com/docview/916340282 https://www.proquest.com/docview/1030869631 https://www.proquest.com/docview/1257854844 https://www.proquest.com/docview/916696795 https://www.proquest.com/docview/922495805 |
| Volume | 107 |
| WOSCitedRecordID | wos000299156100009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1360-0443 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007894 issn: 0965-2140 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELeg5YEXvhnZxmQkNMFDpsZ24oS30qwgsVVo6ljfLMexp2pTMiUt2t_HX8bZ-WCVxjQh3qL4fHFyH_7ZOd8h9D4aSZ0TaXxKJfEZ0drPAsl9QKYxVTqWxuUp-HHEZ7N4sUi-t_FP9ixMkx-i33CzluH8tTVwmdWbRk4jG5rIaJuJk9IoOQA8OSSgxmyAhunJ9PSo98s8dmURbboTn8C6YjOu51ZeG5PV0H7369uQ6CawdTPT9On_fKdn6EmLT_G4Uajn6IEuXqDd5hAvPtOXRlYa7-PuRlldvES_xnm-dOcjcBfIh92usa6xLHIMGBPP1tXKnYjEpcGTqqtacYAbp-JaLF33dwDn1foc18tVk4r8k2ssi_PSEqquAgwGyL3Z7Qa7ZgiOJAVmzVjsFf4z3g-Hx5M0HX98hU6nh_PJV7-tDeGrEECMb0ZEEZqHWU654jaDkEkMywEcwvrWKB0REkjGc5pEJlcyJowaqcEZAeIlJlT0NRoUZaHfIBzSKGQyIaGCqToLEjnSMuAyzniSaODvId4pgVBt4nRbv-NS3FhAgdiEFZuwYhNObOLaQ0Hf86pJHnKPPvtOz_oOsrqwwXc8FGezL2L-eT4_OWbfxNRDO50iitbv1ALAPmV2Ge2hd30rOAz7F0gWulzXwtaViyPwu8EdNNaRw1qWMQ_hv9DAo4ALT8I7SIitbB6PgGSrsZT-rQBpgmjoyEORM4h7fx8xTlN7tf2vHXfQY7hNmsj7XTRYVWv9Fj1SP1fLutpDD_ki3mtdx28ixmo3 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQiwQvjG-yDTASmuAhU2I7ccJbaVaG1lZo6tjeLNexp2pTgtIW7e_jL-PsfLBKY5oQb1F8vjjx3fl3zvkOofdxIHVOpPEplcRnRGt_HkruAzJNqNKJNC5Pwfcxn06Ts7P0W1MOyJ6FqfNDdBtuVjOcvbYKbjekN7WcxjY2kdEmFSelcboPgLLPQKqiHupnx6OTcWeYeeLqItp8Jz4Bx2IzsOdGXhurVd9--KuboOgmsnVL02jrv77UY_SoQah4UIvUE3RPF0_Rbn2MF5_qSyMrjfdwe6OsLp6hX4M8X7gTErgN5cNu31gvsSxyDCgTT9fVyp2JxKXBw6qtW7GPa7PiWixd-38A59X6HC8XqzoZ-SfXWBbnpSVUbQ0YDKB7s9s1dvUQHEkGzOqx2Cv8Z7wfDibDLBt8fI5ORgez4aHfVIfwVQQwxjcBUYTm0TynXHGbQ8ikhuUAD8HDNUrHhISS8ZymscmVTAijRmowR4B5iYkUfYF6RVnoVwhHNI6YTEmkYLGeh6kMtAy5TOY8TTXw9xBvpUCoJnW6reBxKa65UDBtwk6bsNMm3LSJKw-FXc8fdfqQO_TZc4LWdZDVhQ2_45E4nX4Rs8-z2fGEHYmRh3ZaSRSN5VkKgPuUWUfaQ--6VjAZ9j-QLHS5XgpbWS6JwfKGt9BYUw7eLGMewn-hgUcBF55Gt5AQW9s8CYDkZa0q3VsB1oSpoYGHYqcRd_4-YpBl9mr7Xzu-RQ8OZ5OxGH-dHu2gh0BC6jj8XdRbVWv9Gt1XP1eLZfWmsSC_AUX1bT8 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQihAvfDPCBhgJTfCQqbGdOOGtNCugddU0dWxvluuPqdqUTGmL9vfxl3F2PlilMU2It6i-uzo53_l3yfkOoQ9JXxpNpA0plSRkxJhwFkkeAjJNqTKptL5OwY8xn0zS09PssGkH5M7C1PUhuhduzjK8v3YGbi61XbdymrjcREabUpyUJtkuAMoei7MErLSXH42Ox51j5qnvi-jqnYQEAov1xJ4bZa3tVj334K9ugqLryNZvTaPH__WmnqBHDULFg3pJPUX3TPEMbdfHePGJubCyMngHtz-U1flz9Gug9dyfkMBtKh_2743NAstCY0CZeLKqlv5MJC4tHlZt34pdXLsVP-Lo2u8DWFerM7yYL-ti5J_9YFmclY5QtT1gMIDudbZr4uopeJIchNVzcVf4z3w_7h0M83zw6QU6Hu1Nh9_CpjtEqGKAMaHtE0WojmeacsVdDSGbWaYBHkKEa5VJCIkk45pmidVKpoRRKw24I8C8xMaKvkQbRVmYVwjHNImZzEisYLOeRZnsGxlxmc54lhmQHyDergKhmtLproPHhbgWQoHahFObcGoTXm3iKkBRx3lZlw-5A8-OX2gdg6zOXfodj8XJ5KuYfplOjw7YvhgFaKtdiaLxPAsBcJ8yF0gH6H03Ci7DfQeShSlXC-E6y6UJeN7oFhrnyiGaZSxA-C808FcghWfxLSTE9TZP-0CyWZtKd1eANUE1tB-gxFvEnZ-PGOS5u3r9r4zv0IPDfCTG3yf7W-ghUJA6DX8bbSyrlXmD7qufy_miets4kN8tPWy6 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Addiction+research+centres+and+the+nurturing+of+creativity.+Monitoring+the+European+drug+situation%3A+the+ongoing+challenge+for+the+European+Monitoring+Centre+for+Drugs+and+Drug+Addiction+%28EMCDDA%29&rft.jtitle=Addiction+%28Abingdon%2C+England%29&rft.au=Mounteney%2C+Jane&rft.au=Lopez%2C+Dominique&rft.au=Zobel%2C+Frank&rft.au=G%C3%B6tz%2C+Wolfgang&rft.date=2012-02-01&rft.issn=0965-2140&rft.volume=107&rft.issue=2&rft.spage=254&rft.epage=258&rft_id=info:doi/10.1111%2Fj.1360-0443.2011.03369.x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0965-2140&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0965-2140&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0965-2140&client=summon |